Evidence map›Paper›PMID 25427681›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2015

Preventive effect of gomisin J from Schisandra chinensis on angiotensin II-induced hypertension via an increased nitric oxide bioavailability.

Byeong Hyeok Ye, Seung Jin Lee, Young Whan Choi, So Youn Park, Chi Dae Kim

Open access · bronzeAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. How does Eucommia leaf extract prevent smooth muscle cell proliferation induced by high-fat diets at the aortic tunica media?Hypertension research : official journal of the Japanese Society of Hypertension · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Byeong Hyeok YeDepartment of Pharmacology, School of Medicine and MRC for Ischemic Tissue Regeneration, Pusan National University, Yangsan, Gyeongnam, Republic of Korea.
Seung Jin LeeDepartment of Pharmacology, School of Medicine and MRC for Ischemic Tissue Regeneration, Pusan National University, Yangsan, Gyeongnam, Republic of Korea.
Young Whan ChoiCollege of Natural Resources & Life Sciences, Pusan National University, Yangsan, Gyeongnam, Republic of Korea.
So Youn ParkDepartment of Pharmacology, School of Medicine and MRC for Ischemic Tissue Regeneration, Pusan National University, Yangsan, Gyeongnam, Republic of Korea.
Chi Dae KimDepartment of Pharmacology, School of Medicine and MRC for Ischemic Tissue Regeneration, Pusan National University, Yangsan, Gyeongnam, Republic of Korea.
Pusan National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gomisin J (GJ) is a small molecular weight lignan found in Schisandra chinensis and has been demonstrated to have vasodilatory activity. In this study, the authors investigated the effect of GJ on blood pressure (BP) in angiotensin II (Ang II)-induced hypertensive mice. In addition, we determined the relative potencies of gomisin A (GA) and GJ with respect to vasodilatory activity and antihypertensive effects. C57/BL6 mice infused s.c. with Ang II (2 μg kg(-1) min(-1) for 2 weeks) showed an increase in BP and a decrease in plasma nitric oxide (NO) metabolites. In the thoracic aortas of Ang II-induced hypertensive mice, a decrease in vascular NO was accompanied by an increase in reactive oxygen species (ROS) production. Furthermore, these alterations in BP, plasma concentrations of NO metabolites and in the vascular productions of NO and ROS in Ang II-treated mice were reversed by the co-administration of GJ (1 and 3 μg kg(-1) min(-1)). In in vitro studies, Ang II decreased the cellular concentration of NO, which was accompanied by a reduction in phosphorylated endothelial nitric oxide synthase (eNOS) and an increase in ROS production. These eNOS phosphorylation and ROS production changes in Ang II-treated cells were also reversed by GJ pretreatment (0-3 μg ml(-1)). Interestingly, the vasodilatory and antihypertensive effects of GJ were more prominent than those of GA. Collectively, an increase in BP in mice treated with Ang II was markedly attenuated by GJ, which was attributed to the preservations of vascular NO bioavailability and eNOS function, and to the inhibition of ROS production in Ang II-induced hypertensive mice.

Indexed as

SchisandraAngiotensin IIAnimalsAntihypertensive AgentsBiological AvailabilityBlood PressureCyclooctanesDioxolesDisease Models, AnimalHypertensionLignansMaleMiceMice, Inbred C57BLNitric OxideNitric Oxide Synthase Type IIIAngiotensin IIAntihypertensive AgentsCyclooctanesDioxolesgomisin JLignansNitric OxideNitric Oxide Synthase Type IIIPlant ExtractsPolycyclic CompoundsReactive Oxygen Speciesschizandrol BVasodilator Agents

Identifiers

PMID25427681
OpenAlexW2068074975

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.